HomeFocus → FDA Approves Most Expensive Drug Ever

FDA Approves Most Expensive Drug Ever Print E-mail
Written by FHI's Week in Review   
Monday, 27 May 2019 11:43

Rob Stein reports for NPR on a new drug developed by a subsidiary of Novartis, in a post dated May 24, 2019:
The federal Food and Drug Administration has approved a gene therapy for a rare childhood disorder that is now the most expensive drug on the market. It costs $2.125 million per patient. But for those patients lucky enough to get it, it appears it can save their lives with a one-time treatment...<The medication treats> spinal muscular atrophy (SMA), a rare disorder caused by a defective gene; the illness destroys the nerves that control muscles.
Read more in the current issue of Week in Review>>

Last Updated on Monday, 17 June 2019 12:02

Website design, development, and hosting provided by